Quitting using Medication

PreclinicalSmall molecule

MMedical University of South Carolina

Quitting using Medication is one of 4 small molecule programs targeting Tobacco Use. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Tobacco UseRecruiting

Tobacco UsePreclinical

Recruiting

Competition

Competitive Landscape

4 competitors in Tobacco Use

#DrugCompanyPhaseTrials

Nicotine Free Cigarettes

Pfizer

Phase 3

2 2

SPECTRUM Cigarettes

WWake Forest University Health Sciences

Phase 1

1 3

Menthol

GSK

Preclinical

1 4

Quitting using Medication

MMedical University of South Carolina

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2028

PreclinicalRecruiting

Tobacco Use

NCT06922617

Clinical

Trials by Indication[1]

Tobacco Use1 trial

Evaluating a Tobacco Harm Reduction Strategy Among Clients Enrolled in Substance Use Disorder Treatment

Recruiting·MMedical University of South Carolina·Preclinical·NCT06922617·240 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Quitting using Medication. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Quitting using Medication compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Quitting using Medication. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Medical University of South Carolina company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMedical University of South Carolina

Quitting using Medication

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2028

Trials by Indication[1]

Tobacco Use1 trial

References

Drug Info

Quick Facts

Related News